3WANG Zhong-cheng (王忠诚). Neurosurgery [M]. Wuhan: Hubei Science Publishing Company (湖北科学技术出版社), 1998,499-501. (in Chinese)
4Ramot Y, Weiss L, Mor A, et al. A study of the clinical differences between women and men with hyperprolactinemia [J],Gynecol Endocrinol 1996,10(6):397-400.
5Berezin M, Shimon I, Hadani M, et al.Prolactinoma in 53 men: clinical characteristics and modes of treatment (male prolactinoma) [J].J Endocrinol Invest,1995,18(6):436-441.
6Cook R J, Uttley D, Bell B A, et al.Prolactinomas in men masquerading as invasive skull base tumors [J].Br J Neurosurg,1994:8(11):51.
7Prelich G, Kostura M, Mashck D R, et al.The cell-cycle regulated proliferating cell nuclear antigen is required for SV40 DNA replication in vitro [J].Nature,1987,326(6112):471-475.
8Day J D, Digiuseppe J A, Yeo C, et al Immunohistochemical evaluation of HER-2/neu expressing in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasma [J].Hum Pathol,1996,27(2):119-124.
9Chaidarun S S, Eggo M C, Sheppard M C, et al.Expession of epidermal growth factor (EGF).Its receptor, and related oncoprotein(c-erbB2)in pituitary tumors and response to EGF in vitro [J].Endocrinology,1994,135(5):2012-2018.